These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8823807)

  • 1. Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast cancer cells.
    Fanciulli M; Valentini A; Bruno T; Citro G; Zupi G; Floridi A
    Oncol Res; 1996; 8(3):111-20. PubMed ID: 8823807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
    Fanciulli M; Bruno T; Giovannelli A; Gentile FP; Di Padova M; Rubiu O; Floridi A
    Clin Cancer Res; 2000 Apr; 6(4):1590-7. PubMed ID: 10778993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose metabolism in adriamycin-sensitive and -resistant LoVo human colon carcinoma cells.
    Fanciulli M; Bruno T; Castiglione S; Del Carlo C; Paggi MG; Floridi A
    Oncol Res; 1993; 5(9):357-62. PubMed ID: 8038456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
    Floridi A; Paggi MG; D'Atri S; De Martino C; Marcante ML; Silvestrini B; Caputo A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4661-6. PubMed ID: 7306982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
    Kiura K; Ohnoshi T; Ueoka H; Takigawa N; Tabata M; Segawa Y; Shibayama T; Kimura I
    Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy metabolism of adriamycin-sensitive and -resistant Ehrlich ascites tumor cells.
    Miccadei S; Fanciulli M; Bruno T; Paggi MG; Floridi A
    Oncol Res; 1996; 8(1):27-35. PubMed ID: 8704284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
    Knouzy B; Dubourg L; Baverel G; Michoudet C
    J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin resistance modulation induced by lonidamine in human breast cancer cells.
    Zupi G; Molinari A; D'Agnano I; Meschini S; Del Bufalo D; Matarrese P; Candiloro A; Calcabrini A; Citro G; Arancia G
    Anticancer Res; 1995; 15(6B):2469-77. PubMed ID: 8669810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
    Floridi A; Paggi MG; Marcante ML; Silvestrini B; Caputo A; De Martino C
    J Natl Cancer Inst; 1981 Mar; 66(3):497-9. PubMed ID: 6937706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of doxorubicin content by the antitumor drug lonidamine in resistant Ehrlich ascites tumor cells through modulation of energy metabolism.
    Floridi A; Bruno T; Miccadei S; Fanciulli M; Federico A; Paggi MG
    Biochem Pharmacol; 1998 Oct; 56(7):841-9. PubMed ID: 9774146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment and post-treatment with lonidamine in human colon carcinoma HT-29 cell line].
    Fuchs AG
    Medicina (B Aires); 2008; 68(1):13-22. PubMed ID: 18416315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Targeting the gene of glucose metabolism for the treatment of advanced gliomas].
    Oudard S; Miccoli L; Dutrillaux B; Poupon MF
    Bull Cancer; 1998 Jul; 85(7):622-6. PubMed ID: 9752269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
    Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O
    Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies.
    Jaroszewski JW; Kaplan O; Cohen JS
    Cancer Res; 1990 Nov; 50(21):6936-43. PubMed ID: 2208159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy.
    Lyon RC; Cohen JS; Faustino PJ; Megnin F; Myers CE
    Cancer Res; 1988 Feb; 48(4):870-7. PubMed ID: 3338082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B; McCauley MD; Safa AR
    Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lonidamine on the utilization of 14C-labeled glucose by human astrocytoma cells.
    Paggi MG; Zupi G; Fanciulli M; Del Carlo C; Giorno S; Laudonio N; Silvestrini B; Caputo A; Floridi A
    Exp Mol Pathol; 1987 Oct; 47(2):154-65. PubMed ID: 2820786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin].
    Chen J; Yuan YW; Zhang JR; Zhou DY
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):124-6. PubMed ID: 12390804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lonidamine on the mitochondrial potential in situ in Ehrlich ascites tumor cells.
    Pulselli R; Amadio L; Fanciulli M; Floridi A
    Anticancer Res; 1996; 16(1):419-23. PubMed ID: 8615647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.
    Mardor Y; Kaplan O; Sterin M; Ruiz-Cabello J; Ash E; Roth Y; Ringel I; Cohen JS
    Cancer Res; 2000 Sep; 60(18):5179-86. PubMed ID: 11016646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.